Irish UFC superstar says in Instagram post that he married his longtime partner after waking from hallucinogenic treatment.
10d
‘I was a kid’: Kenan Thompson opens up on losing $1.5 million and what prompted his ‘SNL’ longevity
The actor and comedian has appeared on “Saturday Night Live” for 23 seasons and more than 440 episodes. Kenan Thompson ...
Federal prosecutors charged a bodyguard assigned to protect the family of Republican gubernatorial candidate Vivek Ramaswamy ...
Dee Devlin has shared never before seen images of her intimate Italian wedding to Conor McGregor. The couple tied the knot in ...
NEW YORK--(BUSINESS WIRE)--Cantor Fitzgerald, a leading global financial services firm, today announced the successful first closing of its acquisition of the UBS O’Connor alternative investment ...
Marvell Technology Inc. (NASDAQ:MRVL) is one of the best stocks to buy for the next 5 years. On December 16, Cantor Fitzgerald analyst C.J. Muse lowered the firm’s price target on Marvell to $100 from ...
Cantor Fitzgerald, a leading global financial services firm, today announced the successful first closing of its acquisition of the UBS O’Connor alternative investment platform, and the transfer of ...
SEALSQ Corp (NASDAQ:LAES) is one of the 10 Best New Penny Stocks to Invest In. On December 18, Cantor Fitzgerald initiated coverage on SEALSQ Corp (NASDAQ:LAES), giving the stock an Overweight rating ...
Semiconductor giants Nvidia (NVDA) and Broadcom (AVGO) appear to be “ripe for outperformance” in 2026, after a recent bout of weakness, Cantor Fitzgerald said on Wednesday. “The AI trade has obviously ...
Fintel reports that on December 23, 2025, Cantor Fitzgerald initiated coverage of Vizsla Silver (NYSEAM:VZLA) with a Buy recommendation. As of December 21, 2025, the average one-year price target for ...
Fintel reports that on December 23, 2025, Cantor Fitzgerald maintained coverage of TeraWulf (NasdaqCM:WULF) with a Overweight recommendation. Analyst Price Forecast Suggests 73.15% Upside As of ...
Hosted on MSN
Cantor Fitzgerald initiates coverage of ArriVent BioPharma (AVBP) with overweight recommendation
Fintel reports that on December 23, 2025, Cantor Fitzgerald initiated coverage of ArriVent BioPharma (NasdaqGM:AVBP) with a Overweight recommendation. Analyst Price Forecast Suggests 85.97% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback